甲状腺癌：聚焦侵袭与转移机制、治疗靶点及药物治疗
Thyroid Cancer: Focus on Invasion and Metastasis Mechanisms, Therapeutic Target and Drug Treatment.
作者信息
Vasko Vasyl
机构信息
Department of Pediatrics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Rd, Bethesda, MD 20814, USA.
出版信息
Cancers (Basel). 2023 Sep 28;15(19):4762. doi: 10.3390/cancers15194762.
Abstract
Understanding the molecular processes driving thyroid cancer invasion, metastasis, and resistance to therapy is essential for the advancement of novel treatment approaches [...].
摘要
了解驱动甲状腺癌侵袭、转移和抗治疗性的分子过程对于新型治疗方法的进展至关重要[……]。
相似文献
1
Thyroid Cancer: Focus on Invasion and Metastasis Mechanisms, Therapeutic Target and Drug Treatment.甲状腺癌：聚焦侵袭与转移机制、治疗靶点及药物治疗
Cancers (Basel). 2023 Sep 28;15(19):4762. doi: 10.3390/cancers15194762.
2
Molecular mechanisms involved in differentiated thyroid cancer invasion and metastasis.分化型甲状腺癌侵袭和转移的分子机制。
Curr Opin Oncol. 2007 Jan;19(1):11-7. doi: 10.1097/CCO.0b013e328011ab86.
3
MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression.微小 RNA-222 通过靶向蛋白磷酸酶 2 调节亚基 Bα表达促进甲状腺乳头状癌的侵袭和转移。
Thyroid. 2018 Sep;28(9):1162-1173. doi: 10.1089/thy.2017.0665. Epub 2018 Aug 21.
4
Expression of ANGPTL2 and its impact on papillary thyroid cancer.血管生成素样蛋白2（ANGPTL2）的表达及其对甲状腺乳头状癌的影响。
Cancer Cell Int. 2019 Jul 30;19:204. doi: 10.1186/s12935-019-0908-9. eCollection 2019.
5
IL-17RB enhances thyroid cancer cell invasion and metastasis via ERK1/2 pathway-mediated MMP-9 expression.白细胞介素-17受体B通过细胞外信号调节激酶1/2通路介导基质金属蛋白酶-9的表达增强甲状腺癌细胞的侵袭和转移。
Mol Immunol. 2017 Oct;90:126-135. doi: 10.1016/j.molimm.2017.06.034. Epub 2017 Jul 15.
6
Long non-coding RNA MEG3 suppresses migration and invasion of thyroid carcinoma by targeting of Rac1.长链非编码RNA MEG3通过靶向Rac1抑制甲状腺癌的迁移和侵袭。
Neoplasma. 2015;62(4):541-9. doi: 10.4149/neo_2015_065.
7
Silencing of PPM1D inhibits cell proliferation and invasion through the p38 MAPK and p53 signaling pathway in papillary thyroid carcinoma.沉默 PPM1D 通过 p38 MAPK 和 p53 信号通路抑制甲状腺乳头状癌细胞的增殖和侵袭。
Oncol Rep. 2020 Mar;43(3):783-794. doi: 10.3892/or.2020.7458. Epub 2020 Jan 9.
8
MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer.微小RNA作为甲状腺癌中细胞迁移和侵袭的关键调节因子。
Biomark Res. 2022 Jun 4;10(1):40. doi: 10.1186/s40364-022-00382-4.
9
Nevirapine inhibits migration and invasion in dedifferentiated thyroid cancer cells.奈韦拉平可抑制去分化甲状腺癌细胞的迁移和侵袭。
Thorac Cancer. 2019 Dec;10(12):2243-2252. doi: 10.1111/1759-7714.13211. Epub 2019 Oct 21.
10
MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs.微小 RNA（miRNAs）在癌症侵袭和转移中的作用：基于转移相关 miRNAs 的治疗方法。
J Mol Med (Berl). 2011 May;89(5):445-57. doi: 10.1007/s00109-010-0716-0. Epub 2011 Jan 14.
本文引用的文献
1
Outcomes of the Tall-Cell Variant of Papillary Thyroid Carcinoma in Patients with Different Ages: A 17-Year Mono-Institutional Experience.不同年龄患者甲状腺乳头状癌高细胞变体的预后：一项为期17年的单机构经验。
Cancers (Basel). 2023 Apr 5;15(7):2152. doi: 10.3390/cancers15072152.
2
Follicular Thyroid Adenoma and Follicular Thyroid Carcinoma-A Common or Distinct Background? Loss of Heterozygosity in Comprehensive Microarray Study.滤泡性甲状腺腺瘤与滤泡性甲状腺癌——共同背景还是不同背景？综合微阵列研究中的杂合性缺失
Cancers (Basel). 2023 Jan 19;15(3):638. doi: 10.3390/cancers15030638.
3
TROP-2, Nectin-4, GPNMB, and B7-H3 Are Potentially Therapeutic Targets for Anaplastic Thyroid Carcinoma.TROP-2、Nectin-4、GPNMB和B7-H3是间变性甲状腺癌潜在的治疗靶点。
Cancers (Basel). 2022 Jan 24;14(3):579. doi: 10.3390/cancers14030579.
4
Impaired Glucose Metabolism, Anti-Diabetes Medications, and Risk of Thyroid Cancer.葡萄糖代谢受损、抗糖尿病药物与甲状腺癌风险
Cancers (Basel). 2022 Jan 22;14(3):555. doi: 10.3390/cancers14030555.
5
TNF-α May Exert Different Antitumor Effects in Response to Radioactive Iodine Therapy in Papillary Thyroid Cancer with/without Autoimmune Thyroiditis.肿瘤坏死因子-α在伴或不伴自身免疫性甲状腺炎的乳头状甲状腺癌中，对放射性碘治疗的反应可能发挥不同的抗肿瘤作用。
Cancers (Basel). 2021 Jul 19;13(14):3609. doi: 10.3390/cancers13143609.
6
Calcium Signaling in the Thyroid: Friend and Foe.甲状腺中的钙信号：亦敌亦友
Cancers (Basel). 2021 Apr 21;13(9):1994. doi: 10.3390/cancers13091994.
7
The Prognostic Role of Postablative Non-Stimulated Thyroglobulin in Differentiated Thyroid Cancer.消融术后非刺激状态下甲状腺球蛋白在分化型甲状腺癌中的预后作用
Cancers (Basel). 2021 Jan 15;13(2):310. doi: 10.3390/cancers13020310.
Zotero 插件